Convalescent Plasma Transfusion

DRUG3 trials

Sponsors

Institute of Liver and Biliary Sciences, India, Qassim University, Inova Health Care Services

Conditions

COVIDCOVID-19Covid-19

Phase 2

Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients

CompletedNCT04346446

Institute of Liver and Biliary Sciences, IndiaCOVID

Start: 2020-04-20End: 2020-05-30Updated: 2020-06-12

Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma

TerminatedNCT04502472

Inova Health Care ServicesCovid-19

Start: 2020-06-06End: 2020-09-30Updated: 2022-01-10

Unknown Phase

Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic

Qassim UniversityCOVID-19

Start: 2020-07-25End: 2020-09-20Target: 200Updated: 2020-07-07

Related Papers

Comparative Analysis of 9 COVID-19 Convalescent Plasma Protocols Registered by Cochrane Central Register of Controlled Trials

Iranian Red Crescent Medical Journal2020-07-31